Detection of JWH-018 metabolites in smoking mixture post-administration urine.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Forensic Science International

• Publication date

  2010-07-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.forsciint.2010.04.003PMID 20430547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabimimetic Indoles, Pyrroles, and Indenes: Structure–Activity Relationships and Receptor Interactions

  2009cited by this paper
• Identification of a cannabinoid analog as a new type of designer drug in a herbal product.

  2009cited by this paper
• Spice: a never ending story?

  2009cited by this paper
• Identification of a cannabimimetic indole as a designer drug in a herbal product

  2009cited by this paper
• Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS

  2006influential reference
• Molecular biology of cannabinoid receptors.

  2005cited by this paper
• The cannabinoid receptors.

  2002cited by this paper
• Design, synthesis and biological activity of rigid cannabinoid CB1 receptor antagonists.

  2002cited by this paper
• Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding.

  2000cited by this paper

• 5-HT2A receptors are involved in the pharmaco-toxicological effects of the synthetic cannabinoids JWH-018 and 5F-PB22: In vivo studies in mice.

  2024cites this paper
• Forensic drug screening by liquid chromatography hyphenated with high-resolution mass spectrometry (LC-HRMS)

  2023cites this paper
• Synthetic cannabinoids (SC)

  2022cites this paper
• Analytical techniques for the detection of novel psychoactive substances and their metabolites

  2022cites this paper
• Comparison between human liver microsomes and the fungus Cunninghamella elegans for biotransformation of the synthetic cannabinoid JWH-424 having a bromo-naphthyl moiety analysed by high-resolution mass spectrometry

  2022cites this paper
• One-step extraction and determination of 513 psychoactive substances, drugs, and their metabolites from hair by LC–MS/MS

  2022cites this paper
• An Update on the Implications of New Psychoactive Substances in Public Health

  2022cites this paper
• Overview of the major classes of new psychoactive substances, psychoactive effects, analytical determination and conformational analysis of selected illegal drugs

  2021cites this paper
• Substance-Induced Psychoses: An Updated Literature Review

  2021cites this paper
• Detection of ADB-BUTINACA Metabolites in Human Urine, Blood, Kidney and Liver.

  2021cites this paper
• Application of a UPLC-MS/MS method for quantitative analysis of 29 synthetic cannabinoids and their metabolites, such as ADB-BUTINACA and MDMB-4en-PINACA in human hair in real cases.

  2021cites this paper
• Simultaneous screening of 239 synthetic cannabinoids and metabolites in blood and urine samples using liquid chromatography-high resolution mass spectrometry.

  2021cites this paper
• Molecularly imprinted polymers in toxicology: a literature survey for the last 5 years

  2021cites this paper
• The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review

  2020cites this paper
• In vitro assessment of the cytotoxic, genotoxic and oxidative stress effects of the synthetic cannabinoid JWH-018 in human SH-SY5Y neuronal cells.

  2020cites this paper
• Rapid and sensitive detection of synthetic cannabinoids JWH-018, JWH-073 and their metabolites using molecularly imprinted polymer-coated QCM nanosensor in artificial saliva

  2020cites this paper
• Sensor Platform with a Custom‐tailored Aptamer for Diagnosis of Synthetic Cannabinoids

  2020cites this paper
• The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice

  2020cites this paper
• JWH-018

  2019cites this paper
• Phenotype-Based Screening of Synthetic Cannabinoids in a Dravet Syndrome Zebrafish Model

  2019cites this paper
• HighResNPS.com: An Online Crowd-Sourced HR-MS Database for Suspect and Non-targeted Screening of New Psychoactive Substances.

  2019cites this paper
• Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?

  2019cites this paper
• Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders

  2019cites this paper
• The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective

  2019influential citation
• Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.

  2019cites this paper
• Newly Emerging Drugs of Abuse and Their Detection Methods: An ACLPS Critical Review.

  2018cites this paper
• Synthetic Cannabinoids (SCs) in Metaphors: a Metaphorical Analysis of User Experiences of Synthetic Cannabinoids in Two Countries

  2018cites this paper
• UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.

  2018cites this paper
• Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures

  2018cites this paper
• Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.

  2018cites this paper
• Psychosis and synthetic cannabinoids.

  2018cites this paper
• Metabolism of the synthetic cannabinoids AMB-CHMICA and 5C-AKB48 in pooled human hepatocytes and rat hepatocytes analyzed by UHPLC-(IMS)-HR-MSE.

  2018cites this paper
• Suspect and non-target screening workflows to investigate the in vitro and in vivo metabolism of the synthetic cannabinoid 5Cl-THJ-018.

  2018cites this paper
• Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH‐018: a phase 1, placebo‐controlled, pilot study

  2018cites this paper
• Metabolic Study of New Psychoactive Substances by Shimpei Watanabe

  2018cites this paper
• Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice

  2018cites this paper
• Metabolism of the synthetic cannabinoid 5F‐PY‐PICA by human and rat hepatocytes and identification of biliary analytical targets by directional efflux in sandwich‐cultured rat hepatocytes using UHPLC‐HR‐MS/MS

  2018cites this paper
• Metabolism of synthetic cannabinoid receptor agonists encountered in clinical casework: major in vivo phase I metabolites of JWH-007, JWH-019, JWH-203, JWH-307, UR-144, XLR-11, AM-2201, MAM-2201 and AM-694 in human urine using LC-MS/MS

  2018cites this paper
• Excretion of metabolites of the synthetic cannabinoid JWH-018 in urine after controlled inhalation.

  2018cites this paper
• Synthetic cannabinoids in biological specimens: a review of current analytical methods and sample preparation techniques.

  2018cites this paper
• Screening of Synthetic Cannabinoids

  2017cites this paper
• Qualitative Analysis and Detection of the Pyrolytic Products of JWH-018 and 11 Additional Synthetic Cannabinoids in the Presence of Common Herbal Smoking Substrates.

  2017cites this paper
• Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis.

  2017cites this paper
• The Psychopharmacology of Novel Synthetic Cannabinoids

  2017cites this paper
• In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA

  2017cites this paper
• Sensitive quantification of 5F-PB-22 and its three metabolites 5F-PB-22 3-carboxyindole, B-22 N-5-hydroxypentyl and PB-22 N-pentanoic acid in authentic urine specimens obtained from four individuals by liquid chromatography–tandem mass spectrometry

  2017cites this paper
• Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA.

  2017cites this paper
• Simultaneous Analysis of 15 Synthetic Cannabinoids in Human Urine by Using Liquid-Chromatography Tandem-Mass Spectrometry

  2017cites this paper
• Cannabis; Epidemiological, Neurobiological and Psychopathological Issues: An Update.

  2017cites this paper
• A snapshot of novel psychoactive substances (legal highs) use in London.

  2017cites this paper
• Sensitive identification and quantitation of parent forms of six synthetic cannabinoids in urine samples of human cadavers by liquid chromatography–tandem mass spectrometry

  2017cites this paper
• Dried haematic microsamples and LC-MS/MS for the analysis of natural and synthetic cannabinoids.

  2017cites this paper
• Determination of cross-reactivity of poly- and monoclonal antibodies for synthetic cannabinoids by direct SPR and ELISA.

  2017cites this paper
• A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.

  2017cites this paper
• User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes

  2017cites this paper
• Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans

  2017cites this paper
• Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.

  2017cites this paper
• A Diagnostic Conundrum: The Spice Sensation

  2016cites this paper
• In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s.

  2016cites this paper
• Determination of selected synthetic cannabinoids and their metabolites by micellar electrokinetic chromatography--mass spectrometry employing perfluoroheptanoic acid-based micellar phase.

  2016cites this paper
• Analysis of Parent Synthetic Cannabinoids in Blood and Urinary Metabolites by Liquid Chromatography Tandem Mass Spectrometry.

  2016influential citation
• A History of the Forensic Applications of Mass Spectrometry

  2016cites this paper
• Simultaneous Analysis of Cannabinoid and Synthetic Cannabinoids in Dietary Supplements Using UPLC with UV and UPLC-MS-MS.

  2016cites this paper
• Biotransformation of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans.

  2016cites this paper
• Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis.

  2016cites this paper
• Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS.

  2016cites this paper
• JWH-018 ω-OH, a shared hydroxy metabolite of the two synthetic cannabinoids JWH-018 and AM-2201, undergoes oxidation by alcohol dehydrogenase and aldehyde dehydrogenase enzymes in vitro forming the carboxylic acid metabolite.

  2016cites this paper
• Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.

  2016cites this paper
• GC-MS Studies on a Series of 1-pentylacylindoles: Regioisomeric Compounds Related to the Synthetic Cannabinoids.

  2016cites this paper
• OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION Review Articles Interpretation of Urine Drug Testing in Pain Patients

  2016cites this paper
• Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay.

  2016cites this paper
• Oral fluid drug analysis in the age of new psychoactive substances.

  2016cites this paper
• Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.

  2016cites this paper
• Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry.

  2016cites this paper
• Chromatographic analysis and survey studies to evaluate the emerging drugs of synthetic cannabinoids in Scotland and Saudi Arabia

  2016influential citation
• Qualitative screening of new psychoactive substances in pooled urine samples from Belgium and United Kingdom.

  2016cites this paper
• 1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry

  2016cites this paper
• Bioanalytical methods for the determination of synthetic cannabinoids and metabolites in biological specimens

  2016cites this paper
• 固相分散抽出—GC/MS 法によるヒト血清中合成カンナビノイドの分析法の検討

  2016cites this paper
• Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.

  2016cites this paper
• Development of a mass spectrometric hydroxyl-position determination method for the hydroxyindole metabolites of JWH-018 by GC-MS/MS.

  2016cites this paper
• Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.

  2016cites this paper
• Retrospective Analysis of Synthetic Cannabinoid Metabolites in Urine of Individuals Suspected of Driving Impaired.

  2016cites this paper
• Determination and identification of synthetic cannabinoids and their metabolites in different matrices by modern analytical techniques - a review.

  2015cites this paper
• Validation of JWH-018 and its metabolites in blood and urine by UPLC-MS/MS: Monitoring in forensic cases.

  2015cites this paper
• Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry.

  2015cites this paper
• High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.

  2015influential citation
• Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices

  2015cites this paper
• Identification of AKB48 and 5 F-AKB48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry

  2015cites this paper
• Cannabinoïdes de synthèse : méthodes analytiques

  2015cites this paper
• Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry.

  2015cites this paper
• An overview of recent developments in the analytical detection of new psychoactive substances (NPSs).

  2015cites this paper
• Study on the mass fragmentation pathway of the synthetic cannabinoids JWH-018 and JWH-073

  2015cites this paper
• A sensitive GC-EIMS method for simultaneous detection and quantification of JWH-018 and JWH-073 carboxylic acid and hydroxy metabolites in urine.

  2015cites this paper
• A community based study of Synthetic Cannabinoid use in Co. Monaghan, Ireland.

  2015influential citation
• Validation of an ELISA Synthetic Cannabinoids Urine Assay

  2015cites this paper
• Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.

  2015cites this paper
• Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue.

  2015cites this paper
• Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies

  2015cites this paper
• Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid.

  2015cites this paper